Literature DB >> 1739615

Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.

P G Koenders1, W H Peters, T Wobbes, L V Beex, F M Nagengast, T J Benraad.   

Abstract

A series of 24 paired samples of colorectal carcinoma and the respective normal colorectal mucosa were analysed for Epidermal Growth Factor Receptor (EGFR) content by means of a standardised ligand binding assay. We, for the first time, found that EGFR levels are statistically significantly higher in normal colorectal mucosa biopsy samples than they are in colorectal carcinoma biopsy samples, the median EGFR levels being 77.5 fmol mg-1 of membrane protein (range 35-239), against 46 fmol mg-1 of membrane protein (range 22-81), respectively, P less than 0.001. In addition, we found that there are significant regional differences in EGFR expression in the normal human colon mucosa. The EGFR levels were significantly higher in samples from the proximal part of the colon than they were in samples from the distal part, the median EGFR levels being 124 fmol mg-1 of membrane protein (range 70-239) vs 55 fmol mg-1 membrane protein (range 35-156), P less than 0.05. The EGFR levels of the colorectal carcinoma samples did not show any regional variation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739615      PMCID: PMC1977742          DOI: 10.1038/bjc.1992.39

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  Growth factor production by human colon carcinoma cell lines.

Authors:  M A Anzano; D Rieman; W Prichett; D F Bowen-Pope; R Greig
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

3.  Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines.

Authors:  U Murthy; M A Anzano; R G Greig
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

4.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Authors:  W Yasui; H Sumiyoshi; J Hata; T Kameda; A Ochiai; H Ito; E Tahara
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

5.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

6.  Epidermal growth factor receptor expression in colorectal cancer.

Authors:  R J Steele; P Kelly; B Ellul; O Eremin
Journal:  Br J Surg       Date:  1990-12       Impact factor: 6.939

7.  Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas.

Authors:  E Rothbauer; K Mann; B Wiebecke; P Borlinghaus; R Lamerz; E Pratschke; H J Krämling; A Pfeiffer
Journal:  Klin Wochenschr       Date:  1989-05-15

8.  Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.

Authors:  P G Koenders; L V Beex; A Geurts-Moespot; J J Heuvel; C B Kienhuis; T J Benraad
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

9.  Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas.

Authors:  I Magnusson; A V Rosen; R Nilsson; A Macias; R Perez; L Skoog
Journal:  Anticancer Res       Date:  1989 Mar-Apr       Impact factor: 2.480

10.  Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.

Authors:  C Liu; A Woo; M S Tsao
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  10 in total

1.  Raf-1 kinase, epidermal growth factor receptors, and mutant Ras proteins in colonic carcinomas.

Authors:  S Eggstein; G Manthey; T Hirsch; F Baas; B U Specht; E H Farthmann
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Additional prognostic factors in right colon cancer staging.

Authors:  Domenico Parmeggiani; Nicola Avenia; Adelmo Gubitosi; Francesco Gilio; Pietro Francesco Atelli; Massimo Agresti
Journal:  Updates Surg       Date:  2011-06-23

3.  Effects of longterm epidermal growth factor treatment on the normal rat colon.

Authors:  P Kissmeyer-Nielsen; L Vinter-Jensen; M Smerup
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Somatic deletions of the polyA tract in the 3' untranslated region of epidermal growth factor receptor are common in microsatellite instability-high endometrial and colorectal carcinomas.

Authors:  Ma Deqin; Zhao Chen; Christopher Nero; Keyur P Patel; Emad M Daoud; Hanyin Cheng; Bojana Djordjevic; Russell R Broaddus; L Jeffrey Medeiros; Asif Rashid; Rajyalakshmi Luthra
Journal:  Arch Pathol Lab Med       Date:  2012-05       Impact factor: 5.534

5.  Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.

Authors:  Svetlana Baranovskaya; Yolanda Martin; Sergio Alonso; Ksenia L Pisarchuk; Mario Falchetti; Yuichi Dai; Sophia Khaldoyanidi; Stan Krajewski; Inna Novikova; Yuri S Sidorenko; Manuel Perucho; Sergei R Malkhosyan
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

6.  Characterisation of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol, and anti-luteinising hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract.

Authors:  F Darro; I Camby; A Kruczynski; J L Pasteels; J Martinez; R Kiss
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

7.  A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts.

Authors:  Simon J Leedham; Pedro Rodenas-Cuadrado; Kimberley Howarth; Annabelle Lewis; Sreelakshmi Mallappa; Stefania Segditsas; Hayley Davis; Rosemary Jeffery; Manuel Rodriguez-Justo; Satish Keshav; Simon P L Travis; Trevor A Graham; James East; Susan Clark; Ian P M Tomlinson
Journal:  Gut       Date:  2012-01-27       Impact factor: 23.059

8.  A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

Authors:  I Zlobec; T Vuong; S Hayashi; D Haegert; L Tornillo; L Terracciano; A Lugli; J Jass
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

9.  Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.

Authors:  Yoshiyuki Yamamoto; Ichinosuke Hyodo; Yoshikatsu Koga; Ryo Tsumura; Ryuta Sato; Toshihumi Obonai; Hirobumi Fuchigami; Fumiaki Furuya; Masahiro Yasunaga; Mitsunori Harada; Yasuki Kato; Atsushi Ohtsu; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2015-03-23       Impact factor: 6.716

10.  Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

Authors:  Marta Rokita; Rafał Stec; Lubomir Bodnar; Radosław Charkiewicz; Jan Korniluk; Marta Smoter; Marzena Cichowicz; Lech Chyczewski; Jacek Nikliński; Wojciech Kozłowski; Cezary Szczylik
Journal:  Onco Targets Ther       Date:  2013-07-24       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.